Role of RhoB in the Regulation of Pulmonary Endothelial and Smooth Muscle Cell Responses to Hypoxia

被引:72
作者
Wojciak-Stothard, Beata [1 ]
Zhao, Lan [1 ]
Oliver, Eduardo [1 ]
Dubois, Olivier [1 ]
Wu, Yixing [1 ]
Kardassis, Dimitris [2 ]
Vasilaki, Eleftheria [3 ]
Huang, Minzhou [5 ]
Mitchell, Jane A. [4 ]
Louise, Harrington [4 ]
Prendergast, George C. [5 ]
Wilkins, Martin R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, Dept Med, London W12 0NN, England
[2] Univ Crete, Sch Med, Iraklion, Greece
[3] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden
[4] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England
[5] Lankenau Inst Med Res, Wynnewood, PA USA
基金
英国生物技术与生命科学研究理事会;
关键词
hypoxia; pulmonary hypertension; Rho GTPases; endothelium; smooth muscle cells; EPIDERMAL-GROWTH-FACTOR; NEURAL CREST CELLS; FARNESYLTRANSFERASE INHIBITORS; ACTIN CYTOSKELETON; KINASE INHIBITORS; HYPERTENSION; TRANSFORMATION; ACTIVATION; MICE; RAC;
D O I
10.1161/CIRCRESAHA.112.264473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: RhoA and Rho kinase contribute to pulmonary vasoconstriction and vascular remodeling in pulmonary hypertension. RhoB, a protein homologous to RhoA and activated by hypoxia, regulates neoplastic growth and vasoconstriction but its role in the regulation of pulmonary vascular function is not known. Objective: To determine the role of RhoB in pulmonary endothelial and smooth muscle cell responses to hypoxia and in pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension. Methods and Results: Hypoxia increased expression and activity of RhoB in human pulmonary artery endothelial and smooth muscle cells, coincidental with activation of RhoA. Hypoxia or adenoviral overexpression of constitutively activated RhoB increased actomyosin contractility, induced endothelial permeability, and promoted cell growth; dominant negative RhoB or manumycin, a farnesyltransferase inhibitor that targets the vascular function of RhoB, inhibited the effects of hypoxia. Coordinated activation of RhoA and RhoB maximized the hypoxia-induced stress fiber formation caused by RhoB/mammalian homolog of Drosophila diaphanous-induced actin polymerization and RhoA/Rho kinase-induced phosphorylation of myosin light chain on Ser19. Notably, RhoB was specifically required for hypoxia-induced factor-1 alpha stabilization and for hypoxia- and platelet-derived growth factor-induced cell proliferation and migration. RhoB deficiency in mice markedly attenuated development of chronic hypoxia-induced pulmonary hypertension, despite compensatory expression of RhoA in the lung. Conclusions: RhoB mediates adaptational changes to acute hypoxia in the vasculature, but its continual activation by chronic hypoxia can accentuate vascular remodeling to promote development of pulmonary hypertension. RhoB is a potential target for novel approaches (eg, farnesyltransferase inhibitors) aimed at regulating pulmonary vascular tone and structure. (Circ Res. 2012;110:1423-1434.)
引用
收藏
页码:1423 / +
页数:30
相关论文
共 64 条
  • [1] Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice
    Abe, Kohtaro
    Tawara, Shunsuke
    Oi, Keiji
    Hizume, Takatoshi
    Uwatoku, Toyokazu
    Fukumoto, Yoshihiro
    Kaibuchi, Kozo
    Shimokawa, Hiroaki
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (06) : 280 - 285
  • [2] RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development
    Adini, I
    Rabinovitz, I
    Sun, JF
    Prendergast, GC
    Benjamin, LE
    [J]. GENES & DEVELOPMENT, 2003, 17 (21) : 2721 - 2732
  • [3] Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system
    Amerongen, GPV
    van Hinsbergh, VWM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 300 - 311
  • [4] Development of farnesyl transferase inhibitors: A review
    Appels, NMGM
    Beijnen, JH
    Schellens, JHM
    [J]. ONCOLOGIST, 2005, 10 (08) : 565 - 578
  • [5] Basic Science of Pulmonary Arterial Hypertension for Clinicians New Concepts and Experimental Therapies
    Archer, Stephen L.
    Weir, E. Kenneth
    Wilkins, Martin R.
    [J]. CIRCULATION, 2010, 121 (18) : 2045 - U175
  • [6] RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific
    Bailly, K
    Ridley, AJ
    Hall, SM
    Haworth, SG
    [J]. CIRCULATION RESEARCH, 2004, 94 (10) : 1383 - 1391
  • [7] Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
  • [8] Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline
    Caruso, Paola
    MacLean, Margaret R.
    Khanin, Raya
    McClure, John
    Soon, Elaine
    Southgate, Mark
    MacDonald, Robert A.
    Greig, Jenny A.
    Robertson, Keith E.
    Masson, Rachel
    Denby, Laura
    Dempsie, Yvonne
    Long, Lu
    Morrell, Nicholas W.
    Baker, Andrew H.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (04) : 716 - U182
  • [9] Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors
    Chau, NM
    Rogers, P
    Aherne, W
    Carroll, V
    Collins, I
    McDonald, E
    Workman, P
    Ashcroft, M
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4918 - 4928
  • [10] Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice
    Chen, Z
    Sun, JZ
    Pradines, A
    Favre, G
    Adnane, J
    Sebti, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) : 17974 - 17978